Arístides Lopez Marquez
Arístides López-Márquez graduated in Biochemistry in 2011 from the Autonomous University of Madrid and obtained his Ph.D. in Molecular Biology from the same university in 2017. He also holds a master's degree in Molecular Biomedicine.
Between 2018 and 2020 he carried out a first postdoctoral stage at the "Severo Ochoa" Molecular Biology Center in Madrid studying new advanced therapies and the generation of models through gene editing by CRISPR / Cas for rare genetically based diseases.
Since 2020 he is a senior postdoctoral researcher expert in new therapies based on gene editing and regulation at the Laboratory for Applied Research in Neuromuscular Diseases of the Institut Sant Joan de Déu.
- Almici E, Chiappini V, López-Márquez A, Badosa-Gallego MC, Blázquez B, Caballero D, Montero J, Natera-de Benito D, Nascimento-Osorio A, Roldán M, Lagunas A, Jimenez-Mallebrera C and Samitier J Personalized in vitro Extracellular Matrix Models of Collagen VI-Related Muscular Dystrophies. Frontiers in Bioengineering and Biotechnology . 10: 851825-851825.
- López-Márquez A, Morín M, Fernández-Peñalver S, Badosa-Gallego MC, Hernández-Delgado A, Natera-de Benito D, Ortez-Gonzalez CI, Nascimento-Osorio A, Grinberg-Vaisman DR, Balcells S, Roldán M, Moreno-Pelayo MÁ and Jimenez-Mallebrera C CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(8): .
- López-Márquez A, Carrasco-López C, Martínez-Cano A, Lemoine P, Pierreux CE and Santisteban P Sox9 is involved in the thyroid differentiation program and is regulated by crosstalk between TSH, TGFß and thyroid transcription factors. SCIENTIFIC REPORTS . 12(1): 2144-2144.